RIBOPRO logo — Dream ahead.

RIBOPRO

Dream ahead.

Founded 2020 The Netherlands The Netherlands 30 employees Seed Total: $3.10M Biotechnology, Health Care

General Information

Company Name RIBOPRO
Founded Year 2020
Location The Netherlands The Netherlands +2
Founders / Decision Makers
Sander van Asbeck  — Co-Founder and Chief Scientific Officer
Employees 30
Industries Biotechnology, Health Care
Funding Stage Seed
Social

Get notified when RIBOPRO moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About RIBOPRO

RIBOPRO, established in 2020, is a burgeoning player in the Biotechnology and Health Care sectors, headquartered in The Netherlands. Embracing the slogan "Dream ahead.," the company specializes in developing high-quality, high-performance RNA products that cater to the growing demand for advanced research tools and therapeutics.

Its unique value proposition lies in offering a blend of both off-the-shelf and customizable RNA solutions at competitive pricing and expedited delivery. This agile approach significantly alleviates the operational hurdles faced by researchers and developers, enabling them to focus more on innovation and application.

Recently, RIBOPRO secured a €1.90M Convertible Note investment from notable investors such as Vlasroot Group, BOM - Brabant Regional Development Agency, and Fredriks Family Office as of 01 January 2024. This funding infused fresh capital into the venture, reinforcing its market position and fueling further growth in the biotechnology landscape.

Taxonomy: RNA products, mRNA design, RNA therapeutics, custom RNA production, off-the-shelf RNA, RNA research tools, contract manufacturing, RNA drug development, mRNA de-immunization, eGFP mRNA, FLuc mRNA, biotechnology services, high-performance RNA, RNA quality assurance, research and development support

Services & Products

mRNA Design and Production
GMP-grade mRNA Manufacturing
LNP Encapsulation
Contract Research Services
Custom mRNA Optimization

Target Customers

Biotech Companies Pharmaceutical Developers Academic Researchers Therapy Innovators mRNA Therapy Developers

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note €1.90M 3 BOM - Brabant Regional Development Agency, Fredriks Family Office 01 Jan 2024
Seed €1.20M 2 BOM - Brabant Regional Development Agency 01 Mar 2021

RIBOPRO Alternatives & Competitors

RIBOPRO vs
Eclipsebio
Eclipsebio United States

Next-generation assays. Data-driven analytics. RNA breakthroughs.

Series A
40 employees
Biotechnology, Life Sciences
RIBOPRO vs
ExonanoRNA
ExonanoRNA United States

We specialize in the design and production of RNA nanoparticles

6 employees
Biotechnology
RIBOPRO vs
CleanNA
CleanNA The Netherlands

Success is just a bead away

16 employees
Manufacturing
Also compare with: RIBOPRO vs BioEcho Life Sciences BioEcho Life Sciences

FAQ About RIBOPRO

Dream ahead.
RIBOPRO was founded in 2020.
RIBOPRO is headquartered in The Netherlands.
RIBOPRO operates in the following industries: Biotechnology, Health Care.
RIBOPRO has approximately 30 employees.
RIBOPRO has completed 2 funding rounds, raising a total of $3.10M. The latest funding stage is Seed.
RIBOPRO offers: mRNA Design and Production, GMP-grade mRNA Manufacturing, LNP Encapsulation, Contract Research Services, Custom mRNA Optimization.
Top alternatives and competitors to RIBOPRO include Eclipsebio, ExonanoRNA, CleanNA, BioEcho Life Sciences, EC BIOLABS. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
RIBOPRO and Eclipsebio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors RIBOPRO and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy